Evidence map›Paper›PMID 22715045›Full record

ArticleSynapse (New York, N.Y.)2012

Presenilin conditional double knockout mice exhibit decreases in drebrin a at hippocampal CA1 synapses.

David Lee, Chiye Aoki

Open access · greenAbstract read
In one paragraph

Article in Synapse (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synaptic protein levels altered in vascular dementia.Neuropathology and applied neurobiology · 2015
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David LeeCenter for Neural Science, New York University, New York 10003, USA.
Chiye Aoki
New York University · US

Funding

Vision Core Grant- Design and Fabrication ModuleP30EY013079 · NEI · NEW YORK UNIVERSITY · PI ANGELAKI, DORA · 2000 to 2025
$14.2M
Role of Presenilins in the SynapseR01NS041783 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Jie Shen · 2001 to 2026
$10.6M
BP-ENDURE at Hunter and NYUR25NS080686 · NINDS · HUNTER COLLEGE · PI Nesha Star Burghardt, GLENN E SCHAFE · 2012 to 2026
$9.2M
STEROIDS AND GABA:PHYSIOLOGY OF RECEPTOR SUBUNIT CHANGESR01DA009618 · NIDA · SUNY DOWNSTATE MEDICAL CENTER · PI SMITH, SHERYL S · 1995 to 2010
$2.7M
Presenilin and APP in the BrainRF1NS041783 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SHEN, JIE · 2021 to 2021
$2.7M
NEI NIH HHS P30 EY013079NIDA NIH HHS 2R01DA009618-10A1NIDA NIH HHS R01 DA009618NINDS NIH HHS NS41783NINDS NIH HHS R01 NS041783NINDS NIH HHS R25 NS080686NINDS NIH HHS RF1 NS041783
6 · The paper itself

Abstract

Presenilin conditional double knockout (PScDKO) mice have been used as animal models to study the development of Alzheimer's disease (AD) phenotypes. Studies to date indicate that these animals exhibit memory dysfunction and decreased synaptic plasticity before the onset of neurodegeneration. Therefore, the current study sought to examine how the loss of presenilin expression leads to these defects. Drebrin A, a neuron-specific actin-binding protein, has been shown to play an important role in the activity-dependent redistribution of the NMDA type of glutamate receptors at the synapse which, in turn, is a critical step for enabling synaptic plasticity. It is hypothesized that defects in the activity dependent redistribution of NMDA receptors in PScDKO mice may be due to loss of drebrin A. In this study, electron microscopic immunocytochemistry (EM-ICC) was used to quantify and locate drebrin A in the CA1 field of the hippocampus of PScDKO mice. The high resolution of EM-ICC allowed for differentiation between drebrin A at the synapse and at nonsynaptic sites, the latter of which would reflect the protein's role in regulating the reserve or degradative pool of NMDA receptors. The results here demonstrate that loss of function of presenilin in mice leads to a decrease in immunoreactivity for drebrin A at both synaptic (54% decrease, P < 0.01) and nonsynaptic areas (40% decrease, P < 0.01) and overall (44% decrease, P < 0.01). The reduction of drebrin A in both synaptic and nonsynaptic locations of the spine may implicate impairment in glutamate receptor trafficking to and from the postsynaptic plasma membrane. In addition, because of reduced drebrin A at nonsynaptic sites, the regulation of the reserve and degradative pools of glutamate receptors may also be impaired, leading to further synaptic dysfunction. Therefore, this study provides evidence to the theory that drebrin A has a causal role in compromising activity-dependent glutamate receptor trafficking in PScDKO mice.

Indexed as

AnimalsCA1 Region, HippocampalImmunohistochemistryMiceMice, Inbred C57BLMice, KnockoutNeuropeptidesPresenilin-1Presenilin-2SynapsesdrebrinsNeuropeptidesPresenilin-1Presenilin-2Psen2 protein, mouse

Identifiers

PMID22715045
PMCPMC4099411
OpenAlexW1973933662

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.